Anti-CD4/ CD4mut monoclonal antibody

Anti-CD4/ CD4mut antibody for FACS & in-vivo assay

Target products collectionGo to CD4/CD4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T10191-Ab-1/ GM-Tg-hg-T10191-Ab-2Anti-Human CD4 monoclonal antibodyHuman
GM-Tg-rg-T10191-Ab-1/ GM-Tg-rg-T10191-Ab-2Anti-Rat CD4 monoclonal antibodyRat
GM-Tg-mg-T10191-Ab-1/ GM-Tg-mg-T10191-Ab-2Anti-Mouse CD4 monoclonal antibodyMouse
GM-Tg-cynog-T10191-Ab-1/ GM-Tg-cynog-T10191-Ab-2Anti-Cynomolgus/ Rhesus macaque CD4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T10191-Ab-1/ GM-Tg-felg-T10191-Ab-2Anti-Feline CD4 monoclonal antibodyFeline
GM-Tg-cang-T10191-Ab-1/ GM-Tg-cang-T10191-Ab-2Anti-Canine CD4 monoclonal antibodyCanine
GM-Tg-bovg-T10191-Ab-1/ GM-Tg-bovg-T10191-Ab-2Anti-Bovine CD4 monoclonal antibodyBovine
GM-Tg-equg-T10191-Ab-1/ GM-Tg-equg-T10191-Ab-2Anti-Equine CD4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T10191-Ab-1/ GM-Tg-hg-T10191-Ab-2; GM-Tg-rg-T10191-Ab-1/ GM-Tg-rg-T10191-Ab-2;
GM-Tg-mg-T10191-Ab-1/ GM-Tg-mg-T10191-Ab-2; GM-Tg-cynog-T10191-Ab-1/ GM-Tg-cynog-T10191-Ab-2;
GM-Tg-felg-T10191-Ab-1/ GM-Tg-felg-T10191-Ab-2; GM-Tg-cang-T10191-Ab-1/ GM-Tg-cang-T10191-Ab-2;
GM-Tg-bovg-T10191-Ab-1/ GM-Tg-bovg-T10191-Ab-2; GM-Tg-equg-T10191-Ab-1/ GM-Tg-equg-T10191-Ab-2
Products NameAnti-CD4 monoclonal antibody
Formatmab
Target NameCD4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CD4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-640Pre-Made Zanolimumab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
    BiosimilarGMP-Bios-INN-965Pre-Made Priliximab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
    BiosimilarGMP-Bios-INN-782Pre-Made Clenoliximab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
    BiosimilarGMP-Bios-ab-257Pre-Made Ibalizumab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
    BiosimilarGMP-Bios-INN-881Pre-Made Keliximab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
    BiosimilarGMP-Bios-ab-594Pre-Made Tregalizumab biosimilar, Whole mAb, Anti-CD4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
    BiosimilarGMP-Bios-INN-773Pre-Made Cedelizumab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
    Target AntigenProducts DevelopingMulti-species CD4/ CD4mut VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAP000215Human CD4 Adenovirus plasmid
    ORF Viral VectorvGMLP004095human CD4 Lentivirus particle
    ORF Viral VectorvGMAP000215Human CD4 Adenovirus particle
    ORF Viral VectorpGMLP004095human CD4 Lentivirus plasmid


    Target information

    Target IDGM-T10191
    Target NameCD4
    Gene ID920,12504,24932,713807,403931,493775,407098,100052502
    Gene Symbol and SynonymsCD4,CD4mut,IMD79,L3T4,Leu-3,Ly-4,OKT4D,p55,T4,W3/25
    Uniprot AccessionP01730,P05540,P16003,P33705
    Uniprot Entry NameCD4_HUMAN,CD4_MACMU,CD4_RAT,CD4_CANLF
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, Immuno-oncology Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000010610
    Target ClassificationCheckpoint-Immuno Oncology

    The target: CD4, gene name: CD4, also named as CD4mut. This gene encodes the CD4 membrane glycoprotein of T lymphocytes. The CD4 antigen acts as a coreceptor with the T-cell receptor on the T lymphocyte to recognize antigens displayed by an antigen presenting cell in the context of class II MHC molecules. The CD4 antigen is also a primary receptor for entry of the human immunodeficiency virus through interactions with the HIV Env gp120 subunit. This gene is expressed not only in T lymphocytes, but also in B cells, macrophages, granulocytes, as well as in various regions of the brain. The protein functions to initiate or augment the early phase of T-cell activation, and may function as an important mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system. Multiple alternatively spliced transcript variants encoding different isoforms have been identified in this gene. [provided by RefSeq, May 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.